15th Apr 2016 14:35
LONDON (Alliance News) - Dechra Pharmaceuticals PLC said Friday that it expects to complete its acquisition of Putney Inc by next Thursday, following the expiration of a mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
The expiration of the waiting period satisfies the primary condition to the closing on the acquisition of Putney, Dechra said.
Dechra agreed to buy Portland based generic animal drugs developer Putney for USD200.0 million in March, to be paid in cash funded by an extension to its existing debit facility and a share placing to raise USD47.1 million.
Shares in Dechra were down 0.4% at 1,183.00 pence Friday afternoon.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L